US Patent Issued to MINGSIGHT PHARMACEUTICALS on Sept. 16 for "PKC inhibitor solid state forms" (British, American Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,807, issued on Sept. 16, was assigned to MINGSIGHT PHARMACEUTICALS INC. (San Diego).

"PKC inhibitor solid state forms" was invented by Kay Olmstead (Escondido, Calif.) and Julian Northen (Sunderland Tyne and Wear, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to various solid state forms of 5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-ylmethyl)piperazin-1-yl]carbonyl}-N-(5-fluoro-2-methylpyrimidin-4-yl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine and methods of making the same. Such forms of 5-{[(2S,5R)-2,5-dimethyl-4-(tetrahydro-2H-pyran-4-ylmethyl)piperazin-1-yl]carbonyl}-N-(5-fl...